2006
DOI: 10.1016/s0022-5347(06)00203-5
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Experience With the N-Shaped Ileal Neobladder: Assessment of Complications, Voiding Patterns, and Quality of Life in our Series of 58 Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2009
2009
2009
2009

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Between January 1987 and December 2002, 189 patients with bladder cancer had a RC and orthotopic neobladder at our institution. We retrospectively reviewed the records of 111 eligible patients who lived for >5 years after surgery, an ileal neobladder (Studer type [12], modified Studer type [13], or Hautmann type [14]) was constructed in 62 patients (58 men and four women); an ascending colonic neobladder (Goldwasser type [15]) in 14 (12 men and two women); a sigmoid colonic neobladder (modified Reddy type [16]) in 21 (15 men and six women); and an ileocolonic neobladder (Mainz type [17]) in 14 (13 men and one woman). In all, 42 patients died with bladder cancer, 14 with other diseases, and 22 were lost to follow‐up at the assessment.…”
Section: Methodsmentioning
confidence: 99%
“…Between January 1987 and December 2002, 189 patients with bladder cancer had a RC and orthotopic neobladder at our institution. We retrospectively reviewed the records of 111 eligible patients who lived for >5 years after surgery, an ileal neobladder (Studer type [12], modified Studer type [13], or Hautmann type [14]) was constructed in 62 patients (58 men and four women); an ascending colonic neobladder (Goldwasser type [15]) in 14 (12 men and two women); a sigmoid colonic neobladder (modified Reddy type [16]) in 21 (15 men and six women); and an ileocolonic neobladder (Mainz type [17]) in 14 (13 men and one woman). In all, 42 patients died with bladder cancer, 14 with other diseases, and 22 were lost to follow‐up at the assessment.…”
Section: Methodsmentioning
confidence: 99%